Fatigue is a common, disabling problem that is highly prevalent in patients with systemic lupus erythematous (SLE). More recently, vitamin D status has been established as a potential contributor to SLE pathogenesis and manifestations, in particular fatigue. This review summarizes the literature regarding the role of vitamin D in SLE, and provides an overview of the recent literature examining the association between vitamin D and fatigue in patients with SLE. Finally, the role of vitamin D supplementation in the treatment of SLE-related fatigue is considered.
JumpRLRobinsonMEArmstrongAEBarnesEVKilbournKMRichardsHB. Fatigue in systemic lupus erythematosus: Contributions of disease activity, pain, depression, and perceived social support. J Rheumatol2005; 32: 1699–1705.
2.
AhnGERamsey-GoldmanR. Fatigue in systemic lupus erythematosus. Int J Clin Rheumtol2012; 7: 217–227.
3.
KruppLBLaRoccaNGMuirJSteinbergAD. A study of fatigue in systemic lupus erythematosus. J Rheumatol1990; 17: 1450–1452.
4.
Da CostaDDritsaMBernatskySet al.Dimensions of fatigue in systemic lupus erythematosus: Relationship to disease status and behavioral and psychosocial factors. J Rheumatol2006; 33: 1282–1288.
5.
TenchCMMcCurdieIWhitePDD'CruzDP. The prevalence and associations of fatigue in systemic lupus erythematosus. Rheumatology (Oxford)2000; 39: 1249–1254.
6.
FonsecaRBernardesMTerrosoGde SousaMFigueiredo-BragaM. Silent burdens in disease: Fatigue and depression in SLE. Autoimmune Dis2014; 2014: 790724.
7.
YuenHKCunninghamMA. Optimal management of fatigue in patients with systemic lupus erythematosus: A systematic review. Ther Clin Risk Manag2014; 10: 775–786.
8.
AbazaNMEl-MallahRMShaabanAet al.Vitamin D deficiency in Egyptian systemic lupus erythematosus patients: How prevalent and does it impact disease activity?. Integr Med Insights2016; 11: 27–33.
9.
Ruiz-IrastorzaGGordoSOlivaresNEgurbideMVAguirreC. Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue disease activity, and damage. Arthritis Care Res (Hoboken)2010; 62: 1160–1165.
10.
KamenDLCooperGSBoualiHShaftmanSRHollisBWGilkesonGS. Vitamin D deficiency in systemic lupus erythematosus. Autoimmun Rev2006; 5: 114–117.
11.
OrbachHZandman-GoddardGAmitalHet al.Novel biomarkers in autoimmune diseases: Prolactin, ferritin vitamin D, and TPA levels in autoimmune diseases. Ann N Y Acad Sci2007; 1109: 385–400.
12.
HolickMFBinkleyNCBischoff-FerrariHAet al.Evaluation, treatment, and prevention of vitamin D deficiency: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab2011; 96: 1911–1930.
13.
LimaGLPaupitzJAikawaNETakayamaLBonfaEPereiraRM. Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: A randomized, double-blind, placebo-controlled trial. Arthritis Care Res (Hoboken)2016; 68: 91–98.
14.
ErogluGEKohlerPF. Familial systemic lupus erythematosus: The role of genetic and environmental factors. Ann Rheum Dis2002; 61: 29–31.
15.
MolokhiaMMcKeigueP. Systemic lupus erythematosus: Genes versus environment in high risk populations. Lupus2006; 15: 827–832.
16.
MorrisDLFernandoMMTaylorKEet al.MHC associations with clinical and autoantibody manifestations in European SLE. Genes Immun2014; 15: 210–217.
17.
BarbhaiyaMCostenbaderKH. Ultraviolet radiation and systemic lupus erythematosus. Lupus2014; 23: 588–595.
18.
JungersPKuttennFLioteFet al.Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. Arthritis Rheum1985; 28: 1243–1250.
LövgrenTElorantaMLBåveUAlmGVRönnblomL. Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG. Arthritis Rheum2004; 50: 1861–1872.
21.
LiuZDavidsonA. Taming lupus – a new understanding of pathogenesis is leading to clinical advances. Nat Med2012; 18: 871–882.
22.
YuYSuK. Neutrophil extracellular traps and systemic lupus erythematosus. J Clin Cell Immunol2013, pp. 4.
KahlenbergJMCarmona-RiveraCSmithCKKaplanMJ. Neutrophil extracellular trap-associated protein activation of the NLRP3 inflammasome is enhanced in lupus macrophages. J Immunol2013; 190: 1217–1226.
25.
Garcia-RomoGSCaielliSVegaBet al.Netting neutrophils are major inducers of type I IFN production in pediatric systemic lupus erythematosus. Sci Transl Med2011; 3: 73ra20.
26.
LandeRGangulyDFacchinettiVet al.Neutrophils activate plasmacytoid dendritic cells by releasing self-DNA-peptide complexes in systemic lupus erythematosus. Sci Transl Med2011; 3: 73ra19.
27.
TerrierBDerianNSchoindreYet al.Restoration of regulatory and effector T cell balance and B cell homeostasis in systemic lupus erythematosus patients through vitamin D supplementation. Arthritis Res Ther2012; 14: R221.
28.
SinghAKamenDL. Potential benefits of vitamin D for patients with systemic lupus erythematosus. Dermatoendocrinol2012; 4: 146–151.
29.
ShahinDEl-FarahatyRMHoussenMEet al.Serum 25-OH vitamin D level in treatment-naïve systemic lupus erythematosus patients: Relation to disease activity, IL-23 and IL-17. Lupus2017; 26: 917–926.
30.
FarajiFRastinMArabFLet al.Effects of 1,25-dihydroxyvitamin D3 on IL-17/IL-23 axis, IFN-γ and IL-4 expression in systemic lupus erythematosus induced mice model. Iran J Basic Med Sci2016; 19: 374–380.
31.
Ben-ZviIAranowCMackayMet al.The impact of vitamin D on dendritic cell function in patients with systemic lupus erythematosus. PLoS One2010; 5: e9193.
32.
RitterhouseLLCroweSRNiewoldTBet al.Vitamin D deficiency is associated with an increased autoimmune response in healthy individuals and in patients with systemic lupus erythematosus. Ann Rheum Dis2011; 70: 1569–1574.
33.
AranowCKamenDLDall'EraMet al.Randomized, double-blind, placebo-controlled trial of the effect of vitamin D3 on the interferon signature in patients with systemic lupus erythematosus. Arthritis Rheumatol2015; 67: 1848–1857.
34.
AttarSMSiddiquiAM. Vitamin D deficiency in patients with systemic lupus erythematosus. Oman Med J2013; 28: 42–47.
35.
AmitalHSzekaneczZSzücsGet al.Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: Is it time to routinely supplement patients with SLE with vitamin D?. Ann Rheum Dis2010; 69: 1155–1157.
36.
YoungKAMunroeMEGuthridgeJMet al.Combined role of vitamin D status and CYP24A1 in the transition to systemic lupus erythematosus. Ann Rheum Dis2017; 76: 153–158.
37.
HeXJDingYXiangWDangXQ. Roles of 1,25(OH)2D3 and vitamin D receptor in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus by regulating the activation of CD4 + T cells and the PKCδ/ERK signaling pathway. Cell Physiol Biochem2016; 40: 743–756.
38.
BogaczewiczJSysa-JedrzejowskaAArkuszewskaCet al.Vitamin D status in systemic lupus erythematosus patients and its association with selected clinical and laboratory parameters. Lupus2012; 21: 477–484.
39.
FoeringKChangAYPietteEWCucchiaraAOkawaJWerthVP. Characterization of clinical photosensitivity in cutaneous lupus erythematosus. J Am Acad Dermatol2013; 69: 205–213.
40.
YapKSMorandEF. Vitamin D and systemic lupus erythematosus: Continued evolution. Int J Rheum Dis2015; 18: 242–249.
41.
CusackCDanbyCFallonJCet al.Photoprotective behaviour and sunscreen use: Impact on vitamin D levels in cutaneous lupus erythematosus. Photodermatol Photoimmunol Photomed2008; 24: 260–267.
42.
ChristakosSAjibadeDVDhawanPFechnerAJMadyLJ. Vitamin D: Metabolism. Rheum Dis Clin North Am2012; 38: 1–11. vii.
43.
MiskovicRPlavsicARaskovicSJovicicZBolpacicJ. Vitamin D status in patients with systemic lupus erythematosus in Serbia: Correlation with disease activity and clinical manifestations. Open Access Maced J Med Sci2015; 3: 256–261.
44.
Ruiz-IrastorzaGEgurbideMVOlivaresNMartinez-BerriotxoaAAguirreC. Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences. Rheumatology (Oxford)2008; 47: 920–923.
45.
HamzaRTAwwadKSAliMKHamedAI. Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: Relation to disease activity. Med Sci Monit2011; 17: CR711–CR718.
46.
TolozaSMColeDEGladmanDDIbañezDUrowitzMB. Vitamin D insufficiency in a large female SLE cohort. Lupus2010; 19: 13–19.
47.
AkenoNMatsunumaAMaedaTKawaneTHoriuchiN. Regulation of vitamin D-1alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol2000; 164: 339–348.
48.
HuismanAMWhiteKPAlgraAet al.Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol2001; 28: 2535–2539.
49.
BarnesTCBucknallRC. Vitamin D deficiency in a patient with systemic lupus erythematosus. Rheumatology (Oxford)2004; 43: 393–394.
50.
LakshminarayananSWalshSMohanrajMRothfieldN. Factors associated with low bone mineral density in female patients with systemic lupus erythematosus. J Rheumatol2001; 28: 102–108.
KapsimalisFRichardsonGOppMRKrygerM. Cytokines and normal sleep. Curr Opin Pulm Med2005; 11: 481–484.
53.
KruegerJMRectorDMChurchillL. Sleep and cytokines. Sleep Med Clin2007; 2: 161–169.
54.
ObalFJrKruegerJM. Biochemical regulation of non-rapid-eye-movement sleep. Front Biosci2003; 8: d520–d550.
55.
OppMR. Cytokines and sleep: The first hundred years. Brain Behav Immun2004; 18: 295–297.
56.
DreisbachAWHendricksonTBeezholdDRiesenbergLASklarAH. Elevated levels of tumor necrosis factor alpha in postdialysis fatigue. Int J Artif Organs1998; 21: 83–86.
57.
GozalDSerperoLDKheirandish-GozalLCapdevilaOSKhalyfaATaumanR. Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing. Sleep2010; 33: 319–325.
PetersonCAHeffernanME. Serum tumor necrosis factor-alpha concentrations are negatively correlated with serum 25(OH)D concentrations in healthy women. J Inflamm (Lond)2008; 5: 10.
60.
WeckerleCEMangaleDFranekBSet al.Large-scale analysis of tumor necrosis factor α levels in systemic lupus erythematosus. Arthritis Rheum2012; 64: 2947–2952.
61.
ResendeALdos ReisLMDiasCBCustódioMRJorgettiVWoronikV. Bone disease in newly diagnosed lupus nephritis patients. PLoS One2014; 9: e106728.
62.
JablonskiKLChoncholMPierceGLWalkerAESealsDR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension2011; 57: 63–69.
63.
BrandtJAChurchillLRehmanAet al.Sleep deprivation increases the activation of nuclear factor kappa B in lateral hypothalamic cells. Brain Res2004; 1004: 91–97.
64.
KubotaTKushikataTFangJKruegerJM. Nuclear factor-kappaB inhibitor peptide inhibits spontaneous and interleukin-1beta-induced sleep. Am J Physiol Regul Integr Comp Physiol2000; 279: R404–R413.
65.
Lefebvre d'HellencourtCMontero-MeneiCNBernardRCouezD. Vitamin D3 inhibits proinflammatory cytokines and nitric oxide production by the EOC13 microglial cell line. J Neurosci Res2003; 71: 575–582.
66.
ShinpoKKikuchiSSasakiHMoriwakaFTashiroK. Effect of 1,25-dihydroxyvitamin D(3) on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine. J Neurosci Res2000; 62: 374–382.
67.
KowalCDegiorgioLALeeJYet al.Human lupus autoantibodies against NMDA receptors mediate cognitive impairment. Proc Natl Acad Sci U S A2006; 103: 19854–19859.
68.
FaustTWChangEHKowalCet al.Neurotoxic lupus autoantibodies alter brain function through two distinct mechanisms. Proc Natl Acad Sci U S A2010; 107: 18569–18574.
69.
ShuYSuQLiaoSet al.Low serum vitamin D levels and anti-N-methyl-d-aspartate receptor encephalitis: A case-control study. Neurochem Int2017; 102: 89–94.
70.
TaySHHoCSHoRCMakA. 25-Hydroxyvitamin D3 deficiency independently predicts cognitive impairment in patients with systemic lupus erythematosus. PLoS One2015; 10: e0144149.
71.
MokCCBirminghamDJHoLYHebertLASongHRovinBH. Vitamin D deficiency as marker for disease activity and damage in systemic lupus erythematosus: A comparison with anti-dsDNA and anti-C1q. Lupus2012; 21: 36–42.
72.
GadoKHGadoTHAbdel SamieRMKhalilNMEmamSLFouadHH. Clinical significance of vitamin D deficiency and receptor gene polymorphism in systemic lupus erythematosus patients. The Egyptian Rheumatologist2017; 39: 159–164.
73.
PostalMLapaATSinicatoNAet al.Depressive symptoms are associated with tumor necrosis factor alpha in systemic lupus erythematosus. J Neuroinflammation2016; 13: 5.
74.
Salman-MonteTCTorrente-SegarraVAlmirallMCorzoPMojalSCarbonell-AbellóJ. Prevalence and predictors of vitamin D insufficiency in supplemented and non-supplemented women with systemic lupus erythematosus in the Mediterranean region. Rheumatol Int2016; 36: 975–985.
75.
ThudiAYinSWandstratAELiQZOlsenNJ. Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci2008; 335: 99–104.
76.
FragosoTSDantasATMarquesCDet al.25-Hydroxyivitamin [sic] D3 levels in patients with systemic lupus erythematosus and its association with clinical parameters and laboratory tests. Rev Bras Reumatol2012; 52: 60–65.
77.
StocktonKAKandiahDAParatzJDBennellKL. Fatigue, muscle strength and vitamin D status in women with systemic lupus erythematosus compared with healthy controls. Lupus2012; 21: 271–278.
